Guardant360 | oncotest
Prostate Cancer
Prostate Cancer

Guardant360

Relating to cancer treatment:

Prostate Cancer

Target patients:

Patients who want to know which targeted treatments would best treat their cancer using a “liquid biopsy” approach

Test description:

Genomic analysis by sequencing 73 genes from a blood sample – a liquid biopsy, in situations:
1. When an invasive biopsy can not be performed, or no tumor tissue remains for the genomic analysis.
2. Management of treatment after development of resistance to targeted treatment.
3. Monitor tumor growth and dynamics in real time.

Type of sample:

Blood sample

Contact Us